RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/19535619http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/19535619http://www.w3.org/2000/01/rdf-schema#comment"CCL2 is a key CC chemokine that has been implicated in a variety of inflammatory autoimmune diseases and in tumor progression and it is therefore an important target for therapeutic intervention in these diseases. Soluble receptor-based therapy is a known approach for neutralizing the in vivo functions of soluble mediators. Owing to the complexity of seven-transmembrane G protein-coupled receptors, efforts to generate neutralizing soluble chemokine receptors have so far failed. We developed a strategy that is based on the generation of short recombinant proteins encoding different segments of a G protein-coupled receptor, and tested the ability of each of them to bind and neutralize its target chemokine. We show that a fusion protein comprised of as few as 20 aa of the third extracellular (E3) domain of the CCL2 receptor, stabilized by the IgG H chain Fc domain (E3-IgG or BL-2030), selectively binds CCL2 and CCL16 and effectively neutralizes their biological activities. More importantly, E3-IgG (BL-2030) could effectively suppress the in vivo biological activity of CCL2, attenuating ongoing experimental autoimmune encephalomyelitis, as well as the development of human prostate tumor in SCID mice."xsd:string
http://purl.uniprot.org/citations/19535619http://purl.org/dc/terms/identifier"doi:10.4049/jimmunol.0802746"xsd:string
http://purl.uniprot.org/citations/19535619http://purl.uniprot.org/core/author"Karin N."xsd:string
http://purl.uniprot.org/citations/19535619http://purl.uniprot.org/core/author"Zohar Y."xsd:string
http://purl.uniprot.org/citations/19535619http://purl.uniprot.org/core/author"Elkeles A."xsd:string
http://purl.uniprot.org/citations/19535619http://purl.uniprot.org/core/author"Wildbaum G."xsd:string
http://purl.uniprot.org/citations/19535619http://purl.uniprot.org/core/author"Ayalon-Soffer M."xsd:string
http://purl.uniprot.org/citations/19535619http://purl.uniprot.org/core/author"Yefenof E."xsd:string
http://purl.uniprot.org/citations/19535619http://purl.uniprot.org/core/author"Klapper L."xsd:string
http://purl.uniprot.org/citations/19535619http://purl.uniprot.org/core/author"Seagal J."xsd:string
http://purl.uniprot.org/citations/19535619http://purl.uniprot.org/core/author"Anunu R."xsd:string
http://purl.uniprot.org/citations/19535619http://purl.uniprot.org/core/author"Izhak L."xsd:string
http://purl.uniprot.org/citations/19535619http://purl.uniprot.org/core/date"2009"xsd:gYear
http://purl.uniprot.org/citations/19535619http://purl.uniprot.org/core/name"J Immunol"xsd:string
http://purl.uniprot.org/citations/19535619http://purl.uniprot.org/core/pages"732-739"xsd:string
http://purl.uniprot.org/citations/19535619http://purl.uniprot.org/core/title"A novel recombinant fusion protein encoding a 20-amino acid residue of the third extracellular (E3) domain of CCR2 neutralizes the biological activity of CCL2."xsd:string
http://purl.uniprot.org/citations/19535619http://purl.uniprot.org/core/volume"183"xsd:string
http://purl.uniprot.org/citations/19535619http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/19535619
http://purl.uniprot.org/citations/19535619http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/19535619
http://purl.uniprot.org/uniprot/#_B4XH68-mappedCitation-19535619http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19535619
http://purl.uniprot.org/uniprot/#_B4XH69-mappedCitation-19535619http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19535619
http://purl.uniprot.org/uniprot/#_P41597-mappedCitation-19535619http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19535619
http://purl.uniprot.org/uniprot/#_P10148-mappedCitation-19535619http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19535619
http://purl.uniprot.org/uniprot/#_L7REX9-mappedCitation-19535619http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19535619